The DOI matches its Crossref record; 83 of the 87 references it cites were found in a registry or an index.
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Open accessAbstract
Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that EGCG displayed increased stability when formulated as dual-drug loaded PEGylated PLGA nanoparticles (EGCG/AA NPs). Oral administration of EGCG/AA NPs in mice resulted in EGCG accumulation in all major organs, including the brain. Pharmacokinetic comparison of plasma and brain accumulation following oral administration of free or EGCG/AA NPs showed that, whilst in both cases initial EGCG concentrations were similar, long-term (5–25 h) concentrations were ca. 5 fold higher with EGCG/AA NPs. No evidence was found that EGCG/AA NPs utilised a specific pathway across the blood-brain barrier (BBB). However, EGCG, empty NPs and EGCG/AA NPs all induced tight junction disruption and opened the BBB in vitro and ex vivo. Oral treatment of APPswe/PS1dE9 (APP/PS1) mice, a familial model of AD, with EGCG/AA NPs resulted in a marked increase in synapses, as judged by synaptophysin (SYP) expression, and reduction of neuroinflammation as well as amyloid β (Aβ) plaque burden and cortical levels of soluble and insoluble Aβ(1-42) peptide. These morphological changes were accompanied by significantly enhanced spatial learning and memory. Mechanistically, we propose that stabilisation of EGCG in NPs complexes and a destabilized BBB led to higher therapeutic EGCG concentrations in the brain. Thus EGCG/AA NPs have the potential to be developed as a safe and strategy for the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In an interesting in vivo study, oral delivery of epigallocatechin-3-gallate (EGCG) NP formulation in an APP/PS1 AD mouse model reduced neuroinflammation and AB plaque (Fig. 3a–c).”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [114]
In the citing paper
“EGCG in combination with PEGylated PLGA NPs (EGCG/AA NPs) displayed increased stability and sustained release with high bioavailability compared to that of free EGCG.”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [114]
In the citing paper
“Furthermore, these data were supported by significantly improved spatial learning and memory (Fig. 3d, e).114”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Flagged first, then by citations
4 of the 87 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 2009, Development and validation of in vitro release testing methods for semisolid formulations, vol. 10, 1
Cited by
Sorted by citations
Items 201–300 of 337
Liu, Y., Yu, S., Chen, Y., Hú, Z., Fan, L., & Liang, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1376955 · Cited by 8
Naseem, M. A., Hussain, Z., Thu, H. E., Khan, S., Sohail, M. F., Sarfraz, R. M., & Mahmood, A. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2342908 · Cited by 8
Selected Flavonoids to Target Melanoma: A Perspective in Nanoengineering Delivery Systems
Coutinho, T. E., Souto, E. B., & Silva, A. M. (2022) · Bioengineering · doi:10.3390/bioengineering9070290 · Cited by 8
Self-citationMohajer, S., Taha, R. M., Hajivand, S., Pirkhezri, M., & Ahmed, A. B. A. (2022) · Journal of Plant Growth Regulation · doi:10.1007/s00344-022-10876-y · Cited by 8
Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9
Microenvironment-tailored nanoassemblies for the diagnosis and therapy of neurodegenerative diseases
Low, L. E., Wang, Q., Chen, Y., Lin, P., Yang, S., Gong, L., Lee, J., Siva, S. P., Goh, B. H., Li, F., et al. (2021) · Nanoscale · doi:10.1039/d1nr02127c · Cited by 8
Gagliardi, A., Voci, S., Ambrosio, N., Fresta, M., Duranti, A., & Cosco, D. (2023) · Antioxidants · doi:10.3390/antiox12020305 · Cited by 8
Ren, J., Jiang, F., Wang, M., Hu, H., Zhang, B., Chen, L., & Dai, F. (2020) · Biomaterials Science · doi:10.1039/d0bm01439g · Cited by 8
The therapeutic efficacy of nanoparticles in the treatment of alzheimer’s disease
Ntondini, T. L., Naki, T., & Alven, S. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02905-w · Cited by 7
Nagaraju, P. G., Ashwini, S., & G., P. P. C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2092446 · Cited by 7
A Review on Diverging approaches to Fabricate Polymeric Nanoparticles
Deshmukh, S., Chaudhari, B., Velhal, A. B., & Redasani, V. K. (2022) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2022.00058 · Cited by 7
Sharma, S. J., Mahajan, S. D., Chevli, K., Schwartz, S. A., & Aalinkeel, R. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022043827 · Cited by 7
Cao, W., Xiong, S., Ji, W., Wei, H., Ma, F., & Mao, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00765 · Cited by 8
Al‐Najjar, A. H., Khalifa, M. K. A., Amin, O. M., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105745 · Cited by 7
Hu, H., Du, W., Zhang, W., & Fang, J. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.023 · Cited by 7
Peptide-based assembled nanostructures that can direct cellular responses
Huang, H., & Kiick, K. L. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac92b5 · Cited by 7
Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer’s disease
Kumbhar, P., Kolekar, K. A., Vishwas, S., Kamble, V., Bashir, B., Patil, K. S., Bhagwat, D. A., Gupta, G., Prasher, P., Singh, M., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01906-9 · Cited by 8
Tutubala, T. E., Egunlusi, A. O., Fisher, D., Dube, A., & Joubert, J. (2025) · ACS Omega · doi:10.1021/acsomega.4c04887 · Cited by 10
Guo, Z., Liu, W., Liu, T., Wang, J., Jiang, H., Liu, X., Weizmann, Y., & Wang, X. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109060 · Cited by 6
Bioactive Compound‐Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review
Singh, A., Maheshwari, S., Yadav, J. P., Kumar, R. K., Verma, A., Singh, S. K., & Prajapati, B. G. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402018 · Cited by 8
Improvements in Phytochemical-Based Drug Delivery Systems
Yadav, S. K., & Puranik, P. (2024) · Springer eBooks · doi:10.1007/978-981-97-8005-1_9 · Cited by 6
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
Yadav, A. K., & Mazahir, F. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220420133059 · Cited by 6
Gajbhiye, K. R., & Soni, V. (2022) · Current Drug Delivery · doi:10.2174/1567201819666220516093425 · Cited by 6
Nanomedicine: Principles, properties, and regulatory issues
Mazahir, F., Bhogale, D., Palai, A. K., & Yadav, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91248-8.00014-3 · Cited by 6
Mishra, M. A., Sahu, P. K., Satapathy, B. S., & Biswal, B. (2024) · Current Nanomaterials · doi:10.2174/0124054615322050240817172547 · Cited by 5
Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
Haque, A., Khan, T., Islam, R. U., & Naseem, S. (2025) · Next Nanotechnology · doi:10.1016/j.nxnano.2025.100233 · Cited by 5
Tea and Blood–Brain Barrier Homeostasis: Potential Mechanisms and Improvement Strategies
Yue, R., Wen, H., He, L., Liu, Y., Zeng, L., & Luo, L. (2025) · Food Frontiers · doi:10.1002/fft2.70125 · Cited by 6
Manzoor, S. I., Ahanger, I. A., Kamli, M. R., Malik, M. A., & Dar, T. A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148293 · Cited by 5
Davidson, C. B., Machado, É. F., Machado, A. K., de Souza, D. V., Pappis, L., Bonazza, G. K. C., Bick, D. L. U., Montagner, T. R. S., Gündel, A., Zanella, I., et al. (2025) · Biology · doi:10.3390/biology14111520 · Cited by 5
Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy
Li, L.-H., Huang, Y., Wang, X., Xu, C.-C., Wu, L., He, K.-L., Han, D., Chang, Z., Wang, J., & Ma, R.-J. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2634566 · Cited by 5
Qi, J., Tian, L., Pang, Y., & Wu, F. (2025) · Molecules · doi:10.3390/molecules30071484 · Cited by 5
Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer’s Disease
Batko, J., Antosz, K., Nowakowska, H., Błażejewska, M., Kowalik, E. M., Beszłej, J. A., & Leszek, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167725 · Cited by 5
Khalifa, M. K. A., Abdel-Sattar, S. A., Amin, O. M., Kohaf, N. A., Zaky, H. S., El-Fattah, M. A. A., Mohammed, K. H. A., Badawi, N. M., Mansoor, I., & Eassa, H. A. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00494-8 · Cited by 8
Neuroprotection induced by epigallocatechin-3-gallate
Tripathi, S., Mishra, R., Shrivastava, R., Srivastava, V. K., & Singh, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00029-4 · Cited by 5
Zhang, Y., Han, S., Yin, W., Zhang, H., Yu, C.-H., Qin, D., Du, Q., & Jin, P. K. (2022) · Food & Function · doi:10.1039/d1fo02890a · Cited by 5
Ali, M. A., Khalil, M. M., Al‐Mokaddem, A. K., Aljuaydi, S. H., Ahmed, M. M., & Khalil, H. M. A. (2022) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2022.110305 · Cited by 5
Bambole, A. N., Meena, S. N., Nandre, V., & Kodam, K. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15232-0.00008-4 · Cited by 5
EGCG attenuates METH self‐administration and reinstatement of METH seeking in mice
Si, Z., Wang, X., Yu, Z., Ruan, Y., Qian, L., Lin, S., Gong, X., Li, L., Huang, J., & Liu, Y. (2023) · Addiction Biology · doi:10.1111/adb.13307 · Cited by 5
Firouzjaei, A. A., & Mohammadi‐Yeganeh, S. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400969 · Cited by 4
Alzheimer’s Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges
Sai Yasasvi, K., Goswami, A. K., Prasad, M. R., Chauhan, V. S., & Yadav, N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02468 · Cited by 4
Wang, L., Xiong, M., Zhang, J., Li, S., Ma, S., Jiang, S., Jiang, Y., & Li, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03215-2 · Cited by 4
Epigallocatechin-3-Gallate-Loaded Nanocarriers for Health Benefits
Garg, N., & Ahmad, F. J. (2020) · Springer eBooks · doi:10.1007/978-981-15-1664-1_15 · Cited by 4
Kühne, B. A., Teixidó, E., Ettcheto, M., Puig, T., Planas, M., Feliu, L., Plà, L., Campuzano, V., Gratacós, E., Fritsche, E., et al. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113506 · Cited by 4
Self-citationYue, L., Asim, M. H., Alamgeer, & Zhang, D. (2025) · ChemistrySelect · doi:10.1002/slct.202501546 · Cited by 4
Therapeutic Potential of Flavonoids in Parkinson’s Disease
Pechlivani, L., Giannakis, A., Sioka, C., Alexiou, G. Α., Konitsiotis, S., & Kyritsis, A. P. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.09.022 · Cited by 3
Tahvilian, M., Tahvilian, A., Karimi, M., Mahmoudi, F., Izadi, Z., & Malvajerd, S. S. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500414 · Cited by 3
Guo, F., Du, Y.-C., Zeng, T., & Zhou, H. (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70458 · Cited by 4
Reevaluating Alzheimer’s disease treatment: Can phytochemicals bridge the therapeutic Gap?
Roy, K. K., Mehta, D. K., & Das, R. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.014 · Cited by 3
Ahmed, M. M. (2025) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2025.107549 · Cited by 3
Widiatmaja, D. M., Haq, A. U. D. U., Purwati, D. D., & Mustika, A. (2022) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2022.13.1.0019 · Cited by 3
Fan, Z., Zhang, J., Wang, X., & Miao, G. (2022) · Journal of Cluster Science · doi:10.1007/s10876-022-02246-1 · Cited by 3
Metal nanoparticles for neurodegenerative diseases
Haque, S., & Patra, C. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00012-5 · Cited by 4
Abu‐El‐Rub, E., Khasawneh, R. R., Almahasneh, F. A., Aloud, B. M., & Zegallai, H. M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220831105257 · Cited by 3
Flavonoids and other polyphenols against SARS-CoV-2
Rehman, S. U., Shafqat, F., Fatima, B., Nawaz, M. N., & Niaz, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95047-3.00014-9 · Cited by 3
Green Tea Extract Solid Dispersion Pellets with Enhanced Permeability for Hyperlipidemia
Patole, V., Gaikwad, P., Kharat, S., Jadhav, P. A., Deshkar, S. S., & Giram, P. S. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040044 · Cited by 3
Esteruelas, G., Ettcheto, M., Haro, I., Herrando‐Grabulosa, M., Gaja‐Capdevila, N., Gomara, M. J., Navarro, X., Espina, M., Souto, E. B., Camins, A., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s479819 · Cited by 3
Self-citationNano-carriers for Natural Therapeutics in Management of Neuropathic Pain
Nigam, K., Ruba, P. H., Kapoor, P., Gabrani, R., & Dang, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41858-8_16 · Cited by 3
Nanotherapeutics of Phytoantioxidants for Parasitic Diseases and Neglected Tropical Diseases
Zothantluanga, J. H., Zonunmawii, Das, P., Sarma, H., & Umar, A. K. (2022) · Wiley eBooks · doi:10.1002/9781119811794.ch16 · Cited by 3
Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases
Ferrão, R., & Rai, A. (2024) · Wiley eBooks · doi:10.1002/9783527837021.ch27 · Cited by 3
Unlocking the Impact of Phyto-bioactive Compounds against Neurodegenerative Disorders
Rahaman, S. M., Ashique, S., Bhowmick, M., Mollick, M., Bhowmick, P., & Kumar, P. (2024) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812320650241015153325 · Cited by 3
Neurodegenerative Disease: Nanotechnology to Rescue
Doke, R. R., Lamkhade, G., Manchare, B. R., & Vinchurkar, K. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_19 · Cited by 3
Maciel-Magalhães, M., Ybarra, D. E., Vega, D. M., Sosa, A. M., Canabarro, B. R., da Silva, F. F. F., Rocha, H. V. A., Martinez, C. S., Prieto, M. J., Delgado, I. F., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c05091 · Cited by 2
Mangla, B., Yadav, S., Kumar, P., & Aggarwal, G. (2025) · Journal of Liposome Research · doi:10.1080/08982104.2025.2594689 · Cited by 2
Application of Plant Based Nanomaterial for Treating Dementia
Asuku, A. O., Adebayo, P. O., Ajibare, A. J., & Ayoola, S. A. (2026) · Nanotechnology in the life sciences · doi:10.1007/978-3-032-13086-0_8 · Cited by 2
Medical applications of stabilized ascorbic acid: a review of recent advances
Kim, Y., & Choi, G. (2023) · Medical Lasers · doi:10.25289/ml.23.032 · Cited by 2
Lopes, L. E. S., Barroso, S. D. S., Caldas, J. K. M., de Vasconcelos, P. R. L., Canuto, K. M., Dariva, C., Santos, K. S., Severino, P. B., Cardoso, J. C., Souto, E. B., et al. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.01.003 · Cited by 2
Self-citationMeng, X., Cui, W., Liang, Q., Zhang, B., & Wei, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30063 · Cited by 2
Nanotherapeutics for Viral Diseases of Animals
Buragohain, L., Mili, B., Bharali, A., & Mazumdar, A. (2024) · Livestock diseases and management · doi:10.1007/978-981-16-1610-5_20 · Cited by 2
Advances in Nanotechnology for Drug Delivery Modulation in Neurodegenerative Diseases
Abdel-Dayem, D., Emara, H. M., Elshafey, B., & Salama, M. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_9 · Cited by 2
Drug and gene delivery for musculoskeletal tissues
Zhang, W., Kilian, E., & Chen, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823893-6.00012-7 · Cited by 2
Saka, R., & Chella, N. (2020) · Sustainable agriculture reviews · doi:10.1007/978-3-030-41842-7_3 · Cited by 2
PLGA-based nanoparticles for treatment of cerebral diseases
Chacko, J. B., & Jose, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91215-0.00018-2 · Cited by 2
Nanoparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations
Sánchez‐López, E., Souto, E. B., Espina, M., Cano, A. C., Ettcheto, M., Camins, A., & García, M. L. (2021) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-76367-1_15 · Cited by 2
Self-citationChacko, L., Nag, S., Dewanjee, S., Ghosh, S., Vallamkondu, J., Mitra, O., Dey, A., Bhuniya, T., Paluru, H. P. R., Reddy, P. H., et al. (2022) · Preprints.org · doi:10.20944/preprints202211.0032.v1 · Cited by 2
Ahmad, M. M., Alshammari, A. O. S., Alshammari, M. A., Alshammari, H. O. A., Aldhabi, B. M., Alruwaytie, M. Q., & Al-hejaili, O. D. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822306813240516113807 · Cited by 1
Curcumin-mediated nanomedicines for wound healing
Hussain, Z., Ali, K. M. A., Safar, Z. F. M. H., Rawas‐Qalaji, M., & Thu, H. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22027-2.00023-3 · Cited by 1
Modern industrial perspective of nanobiosystems
Babu, M. R., Mishra, Y., Rahaman, S. A., Guptha, P. M., Venkateswarlu, G., Gadewar, M. M., & Suddikattu, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90252-6.00014-1 · Cited by 1
A self-assembled nano-spray formulation for synergistic therapy of anti-inflammation and skin repair
Pan, Q., Zhang, S., Yan, X., Guo, J., Li, B., & Yuan, P. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101067 · Cited by 1
Ge, X., Cai, Y., Dai, H., Jiang, Y., Luo, S., Zhang, X., & Zhu, Y. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2024.09.003 · Cited by 1
Polymeric Nanocarriers for Enhanced Blood-Brain Barrier Permeation in Neurological Drug Delivery
Talele, C., Aundhia, C. J., Talele, D. R., Shah, N., Kumari, M., & Sadhu, P. (2025) · Micro and Nanosystems · doi:10.2174/0118764029366173250706232958 · Cited by 1
Zhou, J., Yang, Y., Zou, H., Jiang, X., Wu, W., Yan, W., Shu, S., Yang, Q., Wang, P., Luo, Z., et al. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139821 · Cited by 1
Amonkar, S. G., & Naik, A. V. (2026) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2026.100075 · Cited by 1
Richard, S. A., Abem, V. K., & Roy, S. K. (2026) · Ibrain · doi:10.1002/ibra.70011 · Cited by 1
Vojdanitalab, K., Naderi, M., Kalkhajeh, S. G., Sabetghadam, A., & Pashaki, S. R. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108200 · Cited by 3
Chen, C., Gan, A., Huang, C., Weng, Y., & Wang, T. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1792350 · Cited by 1
Mazahir, F., Rahi, V., Kumar, A., Kaundal, R. K., & Yadav, A. K. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.102934 · Cited by 1
Nasr, A. M., Motaal, A. A. A., Gad, S., Ghorab, M. M., Ghanem, H. A., Kamel, H. A., Mansour, D. F., Elmeligy, S. A., Ibrahim, F. E. A., & Elwahab, N. H. A. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00952-5 · Cited by 1
Ilić, B. S. (2026) · Biomolecules · doi:10.3390/biom16050734 · Cited by 1
Advancements in delivery of herbal drugs for cognitive disorders
Sapkal, N. P., & Daud, A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00024-0 · Cited by 1
Stagni, F., Guidi, S., & Bartesaghi, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817986-4.00053-5 · Cited by 1
Nanocarriers systems for brain targeted drug delivery and diagnosis
Shah, M. R., Imran, M., & Ullah, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821093-2.00011-6 · Cited by 1
Research progress of EGCG in the treatment of Alzheimer's disease
Meng, L. (2022) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2022.040609 · Cited by 1
Song, C., Ming, W., Chune, L., Zhang, J., & Xi-ping, L. (2023) · World Journal of Public Health · doi:10.11648/j.wjph.20230802.11 · Cited by 1
Singh, M., & Jindal, D. (2023) · Lecture notes in mechanical engineering · doi:10.1007/978-981-99-3386-0_6 · Cited by 2
Nanotechnological Drug Delivery Strategies in Epilepsy
Esteruelas, G., Bonilla-Vidal, L., Ettcheto, M., Haro, I., Gomara, M. J., Souto, E. B., Espina, M., Camins, A., García, M. L., Sánchez‐López, E., et al. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_14 · Cited by 1
Self-citationWang, Y., Zhu, D., & Yu, H. (2024) · Biomedical engineering · doi:10.5772/intechopen.1005186 · Cited by 1
Rawat, A., Sahu, S., Singh, L., Shukla, P., & Mishra, S. S. (2024) · Smart nanomaterials technology · doi:10.1007/978-981-97-0308-1_15 · Cited by 1
A recent review on polymeric nanoparticles: Structure, Classification, and preparation methods
Gad, S., awd, H., Ghorab, M. M., Elwahab, N. H. A., & Nasr, A. M. (2024) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2024.285214.1293 · Cited by 1
Khan, S. A., Qamar, Z., Rohilla, A., Singh, P. P., Parvez, S., Baboota, S., & Ali, J. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128348877241202053633 · Cited by 1
Mude, L., Swain, S. S., Karri, V. V. S. R., Kuppusamy, G., & Subramaniyan, V. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_11 · Cited by 1
Metadata
- Authors
- Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., Camins, A., Turowski, P., & García, M. L.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- University College London (GB)
- Hospital Sant Joan de Déu Barcelona (ES)
- Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona (ES)
- Universitat de Barcelona (ES)
- University of Coimbra (PT)
- Corresponding author
- Turowski, Patric
- García, Maria Luisa
- ORCID
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 301
- Pages
- 62-75
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC6510952
- OpenAlex
- W2920901214
- Cited by
- 337
- References
- 87
- Citations by year
- 2026: 31 · 2025: 55 · 2024: 45 · 2023: 52 · 2022: 58 · 2021: 49 · 2020: 38 · 2019: 8
- FWCI
- 26.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Controlled Release (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc-nd)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation (FS/16/26/32193)
- Ministerio de Ciencia e Innovación (PI2016/01, SAF2017-84283-R, MAT 2014-59134-R, CB06/05/0024)
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- European Regional Development Fund
- Generalitat de Catalunya (CVE-DOGC-B-14206020-2014)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Agricultural and Biological Sciences › Food Science › Tea Polyphenols and Effects
- Keywords
- epigallocatechin gallate, vitamin C, Alzheimer's disease, APP/PS1 mice, blood-brain barrier disruption, tight junctions, oral bioavailability, brain accumulation, amyloid-beta, neuroinflammation, synaptophysin, spatial learning and memory, drug stability
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Alzheimer Disease, Animals, Antioxidants, Ascorbic Acid, Brain, Catechin, Disease Models, Animal, Drug Carriers, Male, Mice, Inbred C57BL, Mice, Transgenic, Polyethylene Glycols, Amyloid beta-Peptides, Endothelial Cells, Rats, Nanoparticles, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
